Nasdaq: $29.19 (-0.44) | AIM: £4.04 (-0.34)
Major Shareholders

HUTCHMED has issued a total of 744,515,660 ordinary shares.  Each Nasdaq-listed American Depositary Share (ADS) equates to five ordinary shares.

For illustrative purposes only, if converted in their entirety, this would be equivalent to 148,903,132 Nasdaq-traded ADSs.

Insofar as HUTCHMED is aware, approximately 47% of the issued share capital of HUTCHMED is not in public hands. Such percentage comprises the shares held by Directors and Hutchison Healthcare Holdings Limited, a significant shareholder of HUTCHMED.

The tables below show major interests in shares of the Company, notified to the Company under the provisions of rule 5 of the Disclosure Rules and Transparency Rules of the U.K. Financial Conduct Authority, which have been incorporated by reference into the Company's Articles of Association.

Last updated: Apr 14, 2021

Significant Shareholders

ShareholderNumber of Ordinary
Shares held
Number of American Depositary Shares HeldApproximate % of Issued Share Capital
Hutchison Healthcare Holdings Limited(1)332,478,77044.66%
The Capital Group Companies, Inc.2,651,0606,183,1554.51%
Prudential plc group10,899,9504,485,0694.48%
General Atlantic Singapore HCM Pte. Ltd.20,000,000(2)2.69%

(1) Hutchison Healthcare Holdings Limited is a private company registered in the British Virgin Islands and carries on business as a holding company. Hutchison Healthcare Holdings Limited is an indirect wholly-owned subsidiary of CK Hutchison Holdings Limited, which is a Cayman Islands company registered and listed in Hong Kong.
(2) General Atlantic is entitled to further subscribe for up to 16,666,670 ordinary shares by exercising a warrant, in part or whole, at any time after July 2, 2020 and ending on January 3, 2022


DirectorNumber of Ordinary
Shares held
Number of American Depositary Shares HeldApproximate % of Issued Share Capital
Christian Hogg10,938,02068,0351.51%
Johnny Cheng2,561,46014,4010.35%
Simon To1,800,000133,2370.33%
Edith Shih700,000100,0000.16%
Weiguo Su74,3170.05%
Dan Eldar19,0008,9930.009%
Tony Mok10,0020.007%
Paul Carter35,2400.005%
Karen Ferrante5,7850.004%
Graeme Jack3,0000.002%

Note: "Held" means any legal or beneficial interest held, whether directly or indirectly, on the account of the Director and such Director's "persons closely associated" (as defined in article 3 of the EU Market Abuse Regulation (No 596/2014)).